Prognostic Impact of Modified H2FPEF Score in Patients Receiving Trans-Catheter Aortic Valve Replacement.
Kousuke AkaoTeruhiko ImamuraShuhei TanakaHiroshi OnodaRyuichi UshijimaMitsuo SobajimaNobuyuki FukudaHiroshi UenoKoichiro KinugawaPublished in: Journal of clinical medicine (2023)
A modified H2FPEF score, which was originally developed to diagnose the presence of HFpEF, could be used to risk-stratify elderly patients receiving TAVR. The clinical utility of this score should be validated in future studies.